Connor, Clark & Lunn Investment Management Ltd.

Holdings History for Ventyx Biosciences, Inc. - Common stock, par value $0.0001 per share (VTYX)

Symbol: VTYX on Nasdaq
Investment type: Equity / Common stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.03%	+0%	$10,872,093	1,203,997	+144,174	+14%	$9.03	Q4 2025
30 Sep 2025	0.01%	+0%	$3,296,050	1,059,823	+114,617	+12%	$3.11	Q3 2025
30 Jun 2025	0.01%	+0%	$2,022,741	945,206	+73,601	+8.4%	$2.14	Q2 2025
31 Mar 2025	0%	0%	$1,002,346	871,605	+78		$1.15	Q1 2025
31 Dec 2024	0.01%	+0%	$1,908,644	871,527	+409,357	+89%	$2.19	Q4 2024
30 Sep 2024	0%	+0%	$1,007,531	462,170	+42,600	+10%	$2.18	Q3 2024
30 Jun 2024	0%	-0%	$969,207	419,570	-56,049	-12%	$2.31	Q2 2024
31 Mar 2024	0.01%	+0.01%	$2,615,905	475,619	+244,967	+106%	$5.50	Q1 2024
31 Dec 2023	0%	+0%	$569,710	230,652	+166,708	+261%	$2.47	Q4 2023
30 Sep 2023	0.01%	+0.01%	$2,220,775	63,944	+37,240	+139%	$34.73	Q3 2023
30 Jun 2023	0%	+0%	$875,891	26,704	+26,704	NEW	$32.80	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.